Pfizer Inc (PFE)

$27.22 +0.73 (2.76%)
Market Cap 150.61B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 8.29
Forward PE 9.04
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 50,691,500
Avg Vol 49,486,949
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 93%
Beta 0.47
Analysts Sell
Price Target $28.43

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
InvestKaki
InvestKaki Feb. 8 at 12:00 AM
$PLTR $CTRA $ORCL $GOOG $PFE https://www.investkaki.com/p/5-interesting-stocks
0 · Reply
lucidi
lucidi Feb. 7 at 10:43 PM
$PFE my LEAPS are already up over 40% and it is just getting started. Got 2 years before they expire. Show me what you got!!
0 · Reply
NovaLedger7
NovaLedger7 Feb. 7 at 3:59 PM
$PFE If volume expands, breakout above resistance could lead to trend confirmation
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 7 at 3:58 PM
$PFE 1W chart is bottoming. 1D RSI at 61 shows strength, while 4H STOCH is overbought. Watching for a 30M CCI reset to add exposure as the broader recovery trend gains confirmation. @DailyAnalysis
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 7 at 3:56 PM
$PFE 1W chart is bottoming. 1D RSI at 61 shows strength, while 4H STOCH is overbought. Watching for a 30M CCI reset to add exposure as the broader recovery trend gains confirmation. @DailyAnalysis
0 · Reply
taxplanr
taxplanr Feb. 7 at 2:22 PM
Would any $BNTX $MRNA $PFE investors like to take a guess how this man got Creutzfeld Jacob disease? https://www.tiktok.com/t/ZTh5PYWTv/
0 · Reply
Thu12nv
Thu12nv Feb. 7 at 1:31 PM
$GDRX Well we are starting to get some coverage now!!! Hopefully we get some upgrades by analyst soon and this thing will really launch 🚀 this was a good read for sure. The earnings report suppose to be really good this quarter too. KEEP ON BUYING!! It doesn’t get any cheaper than this! Good luck everyone Hopefully $PFE and $LLY can maybe get involved or give us a mention. Join us, we will take this stock to $10. Atleast that’s the goal for this year 🫶🏽 https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/goodrx-holdings-incs-nasdaqgdrx-biggest-owners-are-retail-in?utm_medium=article&utm_source=robinhood
0 · Reply
HarrisMint
HarrisMint Feb. 7 at 11:14 AM
$PEP $NOW $QBTS $SOFI $PFE Only one i played this week was PFE in which I just took about a 100% gain and left. PEP, NOW, SOFI and maybe QBTS is on the table this week. Have a blessed weekend. Always remember that you are not in this alone, we all fail, failure is ok. It's a matter how you deal with failure :-) Take care.
0 · Reply
Blizzy
Blizzy Feb. 7 at 6:28 AM
$PFE can you imagine how hard this stock would rocket if Bourla was replaced??!!! One can dream… 😴 🚀 🌙
0 · Reply
Blizzy
Blizzy Feb. 7 at 6:23 AM
$PFE checking in here. Man what a choppy chart!!! Here’s the StockTwits 6-month chart with creative artistic license overlay. Could it actually be breaking out finally or another head fake rug pull coming!??? If > $28 then it could be real.
1 · Reply
Latest News on PFE
Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 1 day ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

Feb 6, 2026, 7:25 AM EST - 1 day ago

14 Ideal 'Safer' Dividend Buys From 29 Of 69 February Graham Value All-Stars (GVAS)

ARCC ARLP CNQ EPD EQNR F FINV

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 1 day ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 2 days ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Feb 3, 2026, 3:00 PM EST - 4 days ago

Pfizer Inc. (PFE) Q4 2025 Earnings Call Transcript

Pfizer: Messy Q4 Earnings Mask An Improving Business

Feb 3, 2026, 2:02 PM EST - 4 days ago

Pfizer: Messy Q4 Earnings Mask An Improving Business

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 4 days ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 4 days ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Feb 3, 2026, 11:56 AM EST - 4 days ago

Pfizer Q4 Earnings Review: This Classic Value Trap Remains As Tempting As Ever

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 4 days ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 4 days ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 4 days ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 4 days ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Feb 3, 2026, 7:28 AM EST - 4 days ago

Pfizer says once-a-month weight-loss drug works as it forecasts profit decline

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Feb 3, 2026, 7:21 AM EST - 4 days ago

Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Feb 3, 2026, 7:18 AM EST - 4 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Feb 3, 2026, 7:02 AM EST - 4 days ago

Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street.

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Feb 3, 2026, 6:57 AM EST - 4 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook

Pfizer beats fourth-quarter profit estimates on strong drug demand

Feb 3, 2026, 6:50 AM EST - 4 days ago

Pfizer beats fourth-quarter profit estimates on strong drug demand

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Feb 3, 2026, 6:45 AM EST - 4 days ago

Pfizer's experimental drug shows up to 12.3% weight loss in mid-stage trial

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Feb 3, 2026, 6:45 AM EST - 4 days ago

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

Feb 3, 2026, 6:40 AM EST - 4 days ago

Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

Feb 2, 2026, 8:42 AM EST - 5 days ago

UK industry body says Sanofi in breach over RSV therapy claims against Pfizer

SNY

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Feb 2, 2026, 1:01 AM EST - 5 days ago

Pfizer Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

Jan 31, 2026, 3:47 AM EST - 7 days ago

5 'Safer' Dividend Buys In Barron's 23 Better January Bets Than T-Bill

BBY CAG EQR FRT KEY LYB MAA

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Jan 30, 2026, 10:31 AM EST - 8 days ago

Pfizer: Buyer Beware, The Risk Outweighs The Reward

Why Dividend Stocks Are Essential For What Comes Next

Jan 30, 2026, 7:30 AM EST - 8 days ago

Why Dividend Stocks Are Essential For What Comes Next

AM CAG EPD ET KMI LLY MPLX

Pfizer: A High-Yield Pharma At A Turning Point

Jan 29, 2026, 9:00 AM EST - 9 days ago

Pfizer: A High-Yield Pharma At A Turning Point

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

Jan 27, 2026, 4:52 PM EST - 11 days ago

US Medicare names Eli Lilly, Pfizer and AbbVie drugs for next Medicare price talks

ABBV LLY

Pfizer vs. Merck Stock And JNJ

Jan 27, 2026, 7:40 AM EST - 11 days ago

Pfizer vs. Merck Stock And JNJ

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Jan 27, 2026, 6:02 AM EST - 11 days ago

Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

Jan 23, 2026, 10:33 AM EST - 15 days ago

Pfizer: Expect Another Double Beating For Q1 (Earnings Preview)

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

Jan 23, 2026, 9:54 AM EST - 15 days ago

December Readers ID'd 9 Ideal 'Safer' Dividends In 40 Dogs

AGNC AGNCP ARLP ECC EFC ET FBRT

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Jan 20, 2026, 12:34 PM EST - 18 days ago

Pfizer CEO Albert Bourla: U.S. drug prices are coming down

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

Jan 20, 2026, 12:18 PM EST - 18 days ago

Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industry

NVO

Novavax enters license agreement with Pfizer for vaccine development

Jan 20, 2026, 7:11 AM EST - 18 days ago

Novavax enters license agreement with Pfizer for vaccine development

NVAX

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Jan 20, 2026, 2:19 AM EST - 18 days ago

Japan's Shionogi boosts ViiV stake to 21.7% as Pfizer exits

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

Jan 19, 2026, 8:10 PM EST - 18 days ago

Invesco Equity And Income Fund Q4 2025 Portfolio Positioning And Performance

BDX DD MSFT ORCL PH Q SLB

MoneyShow's Best Investment Ideas For 2026: Part 7

Jan 19, 2026, 2:20 PM EST - 19 days ago

MoneyShow's Best Investment Ideas For 2026: Part 7

PLD PLG PM QUIK RCAT

Pfizer: Rebound Has Just Started

Jan 16, 2026, 1:08 PM EST - 22 days ago

Pfizer: Rebound Has Just Started

Pfizer: The Most Intriguing Value Play Of 2026

Jan 15, 2026, 8:58 AM EST - 23 days ago

Pfizer: The Most Intriguing Value Play Of 2026

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Jan 13, 2026, 6:11 AM EST - 25 days ago

Pfizer's Patent Cliff, Rising Debt, And The Fight To Stay A Buy

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Jan 12, 2026, 6:43 PM EST - 26 days ago

Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 3:16 PM EST - 26 days ago

Pfizer Inc. (PFE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Jan 10, 2026, 10:00 AM EST - 4 weeks ago

Pfizer's BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

Healthy Returns: What to expect from pharma at the JPM conference

Jan 9, 2026, 12:57 PM EST - 4 weeks ago

Healthy Returns: What to expect from pharma at the JPM conference

AMGN AZN BMY LLY MRK NVO

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Jan 8, 2026, 8:00 AM EST - 4 weeks ago

Gordian Bio Announces Research Collaboration with Pfizer to Accelerate In Vivo Target Discovery in Obesity

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Jan 7, 2026, 2:16 PM EST - 4 weeks ago

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Quant Q&A With Steven Cress

Jan 7, 2026, 7:00 AM EST - 4 weeks ago

Quant Q&A With Steven Cress

CLS CRDO ET FIX MRK

America's new vaccine doctrine for children replaces data with dogma

Jan 6, 2026, 11:55 AM EST - 4 weeks ago

America's new vaccine doctrine for children replaces data with dogma

MRNA

InvestKaki
InvestKaki Feb. 8 at 12:00 AM
$PLTR $CTRA $ORCL $GOOG $PFE https://www.investkaki.com/p/5-interesting-stocks
0 · Reply
lucidi
lucidi Feb. 7 at 10:43 PM
$PFE my LEAPS are already up over 40% and it is just getting started. Got 2 years before they expire. Show me what you got!!
0 · Reply
NovaLedger7
NovaLedger7 Feb. 7 at 3:59 PM
$PFE If volume expands, breakout above resistance could lead to trend confirmation
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 7 at 3:58 PM
$PFE 1W chart is bottoming. 1D RSI at 61 shows strength, while 4H STOCH is overbought. Watching for a 30M CCI reset to add exposure as the broader recovery trend gains confirmation. @DailyAnalysis
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 7 at 3:56 PM
$PFE 1W chart is bottoming. 1D RSI at 61 shows strength, while 4H STOCH is overbought. Watching for a 30M CCI reset to add exposure as the broader recovery trend gains confirmation. @DailyAnalysis
0 · Reply
taxplanr
taxplanr Feb. 7 at 2:22 PM
Would any $BNTX $MRNA $PFE investors like to take a guess how this man got Creutzfeld Jacob disease? https://www.tiktok.com/t/ZTh5PYWTv/
0 · Reply
Thu12nv
Thu12nv Feb. 7 at 1:31 PM
$GDRX Well we are starting to get some coverage now!!! Hopefully we get some upgrades by analyst soon and this thing will really launch 🚀 this was a good read for sure. The earnings report suppose to be really good this quarter too. KEEP ON BUYING!! It doesn’t get any cheaper than this! Good luck everyone Hopefully $PFE and $LLY can maybe get involved or give us a mention. Join us, we will take this stock to $10. Atleast that’s the goal for this year 🫶🏽 https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/goodrx-holdings-incs-nasdaqgdrx-biggest-owners-are-retail-in?utm_medium=article&utm_source=robinhood
0 · Reply
HarrisMint
HarrisMint Feb. 7 at 11:14 AM
$PEP $NOW $QBTS $SOFI $PFE Only one i played this week was PFE in which I just took about a 100% gain and left. PEP, NOW, SOFI and maybe QBTS is on the table this week. Have a blessed weekend. Always remember that you are not in this alone, we all fail, failure is ok. It's a matter how you deal with failure :-) Take care.
0 · Reply
Blizzy
Blizzy Feb. 7 at 6:28 AM
$PFE can you imagine how hard this stock would rocket if Bourla was replaced??!!! One can dream… 😴 🚀 🌙
0 · Reply
Blizzy
Blizzy Feb. 7 at 6:23 AM
$PFE checking in here. Man what a choppy chart!!! Here’s the StockTwits 6-month chart with creative artistic license overlay. Could it actually be breaking out finally or another head fake rug pull coming!??? If > $28 then it could be real.
1 · Reply
Spartacus84
Spartacus84 Feb. 6 at 11:31 PM
$PFE finally green afrer 4 years..enjoyed the divi in the meantime while averaging down. Better days are coming.. possiby able to sell CC👌🏼
0 · Reply
Typecheck
Typecheck Feb. 6 at 11:08 PM
$PFE wild market. What will come next week? Maybe bobbing up and down with the market.
0 · Reply
Delta_Trader_
Delta_Trader_ Feb. 6 at 9:56 PM
$PFE Cause it’s true Value here
0 · Reply
Cash_loot
Cash_loot Feb. 6 at 9:21 PM
$PFE Ohhh I was wrong, Not a Divy run, Ex Date already passed on 01/23/26, Pay date of 03/06/26 So, Why is this running?
1 · Reply
Kgra
Kgra Feb. 6 at 8:59 PM
$PFE nice close and rebound
0 · Reply
notreload_ai
notreload_ai Feb. 6 at 8:55 PM
Analysts say $PFE listing Chantix on TrumpRx may support $ACHV and boost confidence in cytisinicline’s approval prospects. https://notreload.xyz/pfizer-chantix-move-seen-boosting-achieve-life-sciences/
0 · Reply
DailyAnalysis
DailyAnalysis Feb. 6 at 8:31 PM
$PFE 1D is carving a bottom as RSI lifts. 1W momentum remains weak, but 4H CCI is showing bullish divergence. Using 30M STOCH to time a tactical entry if resistance on the daily chart breaks. @DailyAnalysis
0 · Reply
Cash_loot
Cash_loot Feb. 6 at 8:29 PM
$PFE Definitely starting to look interesting over here. on sidelines waiting to see if just a Divy run
0 · Reply
Micheal_Pothead
Micheal_Pothead Feb. 6 at 8:22 PM
$PFE great day, crazy manipulation still though haha
0 · Reply
Yonia
Yonia Feb. 6 at 8:00 PM
$PFE a penny a minute 😂
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Feb. 6 at 8:00 PM
$PFE you are hated until you are loved.... ;-)
1 · Reply
Tiger65
Tiger65 Feb. 6 at 7:57 PM
$PFE Now we almost made it. We have to cross 27.68 to officially enter the buy and moonshot zone. We'll make it, I am very confident. Someone interested in another turnaround story might have a look at $WU. It just crossed 10 and holding up nicely.
0 · Reply